Anti-CCDC162P monoclonal antibody

Pre-made anti-CCDC162P monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CCDC162P/CCDC162P products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2864-Ab-1/ GM-Tg-hg-IP2864-Ab-2Anti-Human CCDC162P monoclonal antibodyHuman
GM-Tg-rg-IP2864-Ab-1/ GM-Tg-rg-IP2864-Ab-2Anti-Rat CCDC162P monoclonal antibodyRat
GM-Tg-mg-IP2864-Ab-1/ GM-Tg-mg-IP2864-Ab-2Anti-Mouse CCDC162P monoclonal antibodyMouse
GM-Tg-cynog-IP2864-Ab-1/ GM-Tg-cynog-IP2864-Ab-2Anti-Cynomolgus/ Rhesus macaque CCDC162P monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2864-Ab-1/ GM-Tg-felg-IP2864-Ab-2Anti-Feline CCDC162P monoclonal antibodyFeline
GM-Tg-cang-IP2864-Ab-1/ GM-Tg-cang-IP2864-Ab-2Anti-Canine CCDC162P monoclonal antibodyCanine
GM-Tg-bovg-IP2864-Ab-1/ GM-Tg-bovg-IP2864-Ab-2Anti-Bovine CCDC162P monoclonal antibodyBovine
GM-Tg-equg-IP2864-Ab-1/ GM-Tg-equg-IP2864-Ab-2Anti-Equine CCDC162P monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2864-Ab-1/ GM-Tg-hg-IP2864-Ab-2; GM-Tg-rg-IP2864-Ab-1/ GM-Tg-rg-IP2864-Ab-2;
GM-Tg-mg-IP2864-Ab-1/ GM-Tg-mg-IP2864-Ab-2; GM-Tg-cynog-IP2864-Ab-1/ GM-Tg-cynog-IP2864-Ab-2;
GM-Tg-felg-IP2864-Ab-1/ GM-Tg-felg-IP2864-Ab-2; GM-Tg-cang-IP2864-Ab-1/ GM-Tg-cang-IP2864-Ab-2;
GM-Tg-bovg-IP2864-Ab-1/ GM-Tg-bovg-IP2864-Ab-2; GM-Tg-equg-IP2864-Ab-1/ GM-Tg-equg-IP2864-Ab-2
Products NameAnti-CCDC162P monoclonal antibody
Formatmab
Target NameCCDC162P
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CCDC162P monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2864-Ag-1Recombinant multi-species CCDC162P/ C6orf183/ C6orf184 protein


    Target information

    Target IDGM-IP2864
    Target NameCCDC162P
    Gene ID221262,102554658
    Gene Symbol and SynonymsC6orf183,C6orf184,C6orf185,CCDC162,CCDC162P
    Uniprot AccessionN/A
    Uniprot Entry Name
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000203799
    Target ClassificationN/A

    The target: CCDC162P, gene name: CCDC162P, also named as C6orf183, C6orf184, C6orf185, CCDC162. This gene is the ortholog of the mouse coiled-coil domain containing 162 gene. This locus is transcribed, but is represented as a unitary pseudogene because there are multiple changes in the coding sequence, including multiple changes that result in premature stop codons, relative to the mouse coding sequence. Transcripts from this locus are expected to encode truncated proteins, and may be candidates for nonsense-mediated decay (NMD). [provided by RefSeq, Sep 2018].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.